Abstract
Recent developments in technology have presented viable dosage alternatives for patients who may have difficulty swallowing tablets or liquids. Traditional tablets and capsules administered with an 8-oz. glass of water may be inconvenient or impractical for some patients. For example, a very elderly patient may not be able to swallow a daily dose of antidepressant. An eight-year-old with allergies could use a more convenient dosage form than antihistamine syrup. A schizophrenic patient in the institutional setting can hide a conventional tablet under his or her tongue to avoid their daily dose of an atypical antipsychotic. A middle-aged woman undergoing radiation therapy for breast cancer may be too nauseous to swallow her H2-blocker. The convenience of administration and improved patient compliance are important in the design of oral drug delivery system which remains the preferred route of drug delivery inspite of various disadvantages. One such problem can be solved in the novel drug delivery system by formulating “mouth dissolving tablets” (MDTs) which disintegrates or dissolves rapidly without water within few seconds in the mouth due to the action of super-disintegrant or maximizing pore structure in the formulation. The review describes the various formulation aspects, technologies developed for MDTs, marketed formulation and drugs used in this research area.
References
Chang RK, Guo X, Burnside B, Couch R. Fast-Dissolving Tablets, Pharm Technol 2000; 24(6):52-58.
Habib W, Khankari R, Hontz J, Fast-Dissolve Drug Delivery System. Crit Rev Ther Drug Carrier Syst 2000;17:61-72.
Chein YW. Oral Drug Delivery and Delivery Systems. 2nd ed. New York: Marcel Dekker; 1992.
Seager H. Drug-deliver Products and the Zydis Fast- dissolving Dosage Form. J Pharm and Pharmacol 1998; 50:375-382.
Anon. Flavors and Flavoring. Int J Pharm Compounding 1997; 1:90-92.
Parakh SR and Gothoskar AV. A review of mouth dissolving tablet technologies. Pharm Tech 2003; 27(11):92‐98.
Habib W, Khankari RK, Hontz J. Fast-dissolve drug delivery systems. Crit Rev Ther Drug Carrier Sys 2000; 17:61-72.
Nail SL and Gatlin LA. Freeze Drying: Principles and Practice, Parenteral Medications, in Pharmaceutical Dosage Forms. 2nd ed. Vol. 2. Marcel Dekker, New York; 1993:163.
Kuchekar BS, Badhan CA and Mahajan HS. Mouth dissolving tablets: A novel drug delivery system. Pharma Times 2003; 35:7‐10.
Mizumoto T, Masuda Y and Fukui M. Intrabuccally dissolving compressed moldings and production process thereof. US Patent 1996; No. 5576014.
Allen LV, Wang B, Davis LD. Rapidly dissolving tablet. US Patent 5,807,576; 1998.
Meyers GL, Battist GE, Fuisz RC. Process and apparatus for making rapidly dissolving dosage units and product there form. PCT Patent WC 95/34293-A1; 1995.
Yarwood RJ, Kearny P and Thomson AR. Process for preparing solid pharmaceutical dosage forms. US Patent 1998; No.5738875.
Kaushik D, Dureja H and Saini TR. Mouth dissolving tablets: A Review. Indian Drugs 2004; 41(4):187‐192.
Gole DJ, Levinson RS and Carbone J. Preparation of pharmaceutical and other matrix systems by solid state dissolution. US Patent 1993; No. 5215756.
Shangraw R, Mitrevej A and Shah M. A new era of tablet disintegrants. Pharm Technol 1980; 4(10):49‐57.
Dobeti L. Fast disintegrating tablets. PCT Patent 1999; No. 44580‐Ai.
Acosta C, Tabare R, and Quali A. Fast‐melt tablet and method of making same. US Patent 1998; No. 5807.
Panigrahi D, Baghel S and Mishra B. Mouth dissolving tablets: An overview of preparation techniques, evaluation and patented technologies. J Pharm Res 2005; 4(3):35‐38.
Dr. Amin FA, Shah T, Bhadani M and Patel M. Emerging trends in development of orally disintegrating tablet technology. pharminfo.net.
Patel BP. Fast dissolving drug delivery systems: An update. pharmainfo.net.
Bi Y, Sunanda H, Yonezawa Y, Danjo K and Lido K. Preparation and evaluation of a compressed tablet rapidly disintegrating in oral cavity. Chem Pharm Bull 1996; 44(11):2121‐2127.
Watanabe Y, Koizumi K, Zama Y, Kiriyama M, Mastumoto Y and Mastumoto M. New compressed tablet rapidly disintegrating in saliva in the mouth using crystalline cellulose and a disintegrant. Bio Pharm Bull 1995; 18(9):1308.
Allen LV and Wang B. Particulate support matrix for making rapidly dissolving tablets. US Patent 1997; No. 5,595,761.
Liang AC and Chen HL. Fast‐dissolving intraoral drug delivery systems. Expert Opin Ther Patents 2001; 11(6):981‐986.
www. ElanNanoCrystal_Technology.html
Biovail Pharmaceuticals. Products. 22 Feb 2002 http://www.biovailpharm.com/products.shtml.
Proulx SM and Melchiorre HA. New Dosage Forms Lead to Confusion. US Pharm. 2001; 26(2):68-70.
Yu D, Roche E. US Patent6, 586,012, July 1, 2003.
Manek S P, Kamat V S. Indian J. Pharm. Sci., 1981, 43 (11–12), 209–212.
Seager H. J. Pharm. Pharmacol., 1998, 50, 375.
Ohta M, Hayakawa E, Ito KS. Tokuno, K. Morimoto, V. Watanabe, WO Patent 9,747,287, 1997.
Hayakawa, E, Ito K, Ohta M, Tokuno S, Morimoto K, Watanabe V. EU Patent 0,914,818, 1999.
Allen LV, Wang B, Davis JD.et al. US patent, 5,807,567, 1998.
Acosta C, Tabare R, Ouali, A et al. US patent, 5, 1998, 807.
Bhandari Dinesh. Recent trends - Fast Dissolving Tablets., pharmainfo.net, 6 (6), 2008.
Caramella C. Int. J. Pharm. Techno. Prod. Mfr., 1984, 5, 1.
Gohel M, Patel M, Aggarwal R, Dev R et al. AAPS Pharm Sci Tech., 2004, 3, 36.
Adel M, Semreen MK, Qato KM et al. Pharm. Tech., 2005, 2, 68-78.
Cousin G, Bruna E, Gendrot E. US Patent 5,464, 632. Nov 7, 1995.
How to cite your article:
Gupta Dilip Kumar, Bajpai Meenakshi, Chatterjee D.P., A review on “Fast mouth dissolving disintegrating tablet and patient counselling points for FDDTs”, Int. J. Res. Dev. Pharm. L. Sci., 2014, 3(3), pp. 949-958.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Copyright (c) 2020 Array